Brez internetne povezave — prikazana je shranjena različica strani.

60 Degrees Pharma…

USUSD
← Na Filter Delnic

60 Degrees Pharmaceuticals, Inc. (US:SXTP) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
60degreespharma.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
WASHINGTON, United States
Izvršni Direktor
Geoffrey Stuart Dow
Zaposleni
3
Delnice v Obtoku
3.52 mio. na dan 2026-08-14
1 Leto: −14.3% · 3 leta: −52.6% (brez razcepov delnic)
DatumDelniceSprememba
14.08.20263.52 mio.+32.3%izdaja (razredčitev)
15.05.20262.66 mio.+0.9%izdaja (razredčitev)
30.03.20262.64 mio.−37.7%odkup
13.11.20254.23 mio.+3.1%izdaja (razredčitev)
13.08.20254.1 mio.+178.7%izdaja (razredčitev)
15.05.20251.47 mio.—brez bistvenih sprememb
27.03.20251.47 mio.obratni razcep 1:1.5
14.11.20242.3 mio.+29.9%izdaja (razredčitev)
14.08.20241.77 mio.−85.4%odkup
15.05.202412.14 mio.+4.9%izdaja (razredčitev)
01.04.202411.57 mio.razcep 2:1
20.11.20235.8 mio.—brez bistvenih sprememb
25.08.20235.8 mio.
Število delnic po poročilih podjetja. Razcep se prepozna po skoku števila za celo število krat.
Prosto Prenosljive Delnice
2.44 mio.
Tržna Kapitalizacija
3.4 mio. USD
Notranje Osebe
19.39%
Institucionalni Vlagatelji
17.11%
Panoga (SIC)
Pharmaceutical Preparations
P/E
izguba
FCF
−8.89 mio. USD
Dolg
150 tis. USD
neto denar
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
0.98 USD · P/NAV 0.90
Balance sheet date30.06.2026
Assets4.28 mio. USD
− Liabilities1.75 mio. USD
= Total equity2.53 mio. USD
− Non-controlling interests−85.8 tis. USD
= NAV (lastniški delež delničarjev podjetja)2.61 mio. USD
− Intangible assets309 tis. USD
= Tangible NAV2.31 mio. USD
Delnice2 659 288
NAV per share0.98 USD
Otipljiv NAV na Delnico0.87 USD
Share price (SXTP)0.8802 USD
P/NAV0.90
NAV history
Balance sheet dateNAVNAV per share
30.06.20262.61 mio. USD0.98 USD
31.03.20264.83 mio. USD1.83 USD
31.12.20253.46 mio. USD2.98 USD
30.09.20254.43 mio. USD1.08 USD
30.06.20252.43 mio. USD1.65 USD
31.03.20254.11 mio. USD2.79 USD
31.12.20244.04 mio. USD28.47 USD
30.09.20246.04 mio. USD3.24 USD
Opis

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksSXTPUSD0.8802 -2.20%navadne delnice

Cena v 3 Mesecih

3M1Y3Y5Y
US:SXTP · USD
dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Kathmere Capital Managem…7.54%265 1002026-06-30
MILLER TYRONE (Chief Fin…≈0.75%26 3702025-01-17
DOW GEOFFREY S (Chief Ex…≈0.69%24 1312026-06-12
Citadel Advisors Llc0.64%22 3622026-06-30
Xtx Topco Ltd0.5%17 6392026-06-30
XU CHERYL (Director)≈0.45%15 8162025-06-03
Kovack Advisors, Inc.0.43%15 0002026-06-30
Geode Capital Management…0.41%14 5512026-06-30
Fidelity Concord Street…0.41%14 3802026-07-31
UBS Group AG0.39%13 5922026-06-30
LANDON KRISTEN (Chief Op…≈0.13%4 5402025-01-17
Barclays Plc0.03%1 0522026-06-30
Osaic Holdings Inc.0%252026-06-30